BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25427720)

  • 1. Effect of warfarin on survival in patients with concomitant left ventricular systolic dysfunction and pulmonary hypertension: a population cohort study.
    Goudie A; Elder D; Deshmukh H; Szwejkowski BR; Lang CC; George J
    Eur J Heart Fail; 2015 Jan; 17(1):90-7. PubMed ID: 25427720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary hypertension predicts all-cause mortality in patients with heart failure: a retrospective cohort study.
    Szwejkowski BR; Elder DH; Shearer F; Jack D; Choy AM; Pringle SD; Struthers AD; George J; Lang CC
    Eur J Heart Fail; 2012 Feb; 14(2):162-7. PubMed ID: 22178623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Left Ventricular Systolic Dysfunction on Response to Warfarin.
    Ather S; Shendre A; Beasley TM; Brown T; Hill CE; Prabhu SD; Limdi NA
    Am J Cardiol; 2016 Jul; 118(2):232-6. PubMed ID: 27241839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of heart rate recovery in patients with heart failure or left ventricular systolic dysfunction.
    Lipinski MJ; Vetrovec GW; Gorelik D; Froelicher VF
    J Card Fail; 2005 Oct; 11(8):624-30. PubMed ID: 16230267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Echocardiographic estimation of pulmonary arterial systolic pressure in acute heart failure. Prognostic implications.
    Merlos P; Núñez J; Sanchis J; Miñana G; Palau P; Bodí V; Husser O; Santas E; Bondanza L; Chorro FJ
    Eur J Intern Med; 2013 Sep; 24(6):562-7. PubMed ID: 23684500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-capillary pulmonary hypertension and right ventricular dilation predict clinical outcome in cardiac resynchronization therapy.
    Chatterjee NA; Upadhyay GA; Singal G; Parks KA; Dec GW; Singh JP; Lewis GD
    JACC Heart Fail; 2014 Jun; 2(3):230-7. PubMed ID: 24952689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Warfarin anticoagulation and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction.
    Al-Khadra AS; Salem DN; Rand WM; Udelson JE; Smith JJ; Konstam MA
    J Am Coll Cardiol; 1998 Mar; 31(4):749-53. PubMed ID: 9525542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary hypertension and right ventricular failure in left ventricular systolic dysfunction.
    Di Salvo TG
    Curr Opin Cardiol; 2012 May; 27(3):262-72. PubMed ID: 22495594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary Hypertension in Heart Failure. Epidemiology, Right Ventricular Function, and Survival.
    Gerges M; Gerges C; Pistritto AM; Lang MB; Trip P; Jakowitsch J; Binder T; Lang IM
    Am J Respir Crit Care Med; 2015 Nov; 192(10):1234-46. PubMed ID: 26181215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of pulmonary hypertension on outcomes of patients with low left ventricular ejection fraction: a propensity analysis.
    Yang C; Li D; Mennett R; Hammond J; Zhang G; Chen D; Lundbye J; Gallagher R
    J Heart Valve Dis; 2012 Nov; 21(6):767-73. PubMed ID: 23409360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality associated with the quality of care of patients hospitalized with congestive heart failure.
    Luthi JC; McClellan WM; Fitzgerald D; Krumholz HM; Delaney RJ; Bratzler DW; Elward K; Cangialos CB; Ballar DJ;
    Int J Qual Health Care; 2002 Feb; 14(1):15-24. PubMed ID: 11871625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term functional and clinical follow-up of patients with heart failure with recovered left ventricular ejection fraction after β-blocker therapy.
    de Groote P; Fertin M; Duva Pentiah A; Goéminne C; Lamblin N; Bauters C
    Circ Heart Fail; 2014 May; 7(3):434-9. PubMed ID: 24563449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy C; Young JB;
    Am Heart J; 2007 Jan; 153(1):82.e1-11. PubMed ID: 17174643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systolic blood pressure at admission as a predictor of the response to initial carperitide therapy in patients hospitalized for acute decompensated heart failure with left ventricular systolic dysfunction.
    Kajimoto K; Sashida Y; Minami Y; Yumino D; Kawarai H; Kasanuki H
    Cardiovasc Drugs Ther; 2009 Dec; 23(6):481-8. PubMed ID: 19937464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Riociguat for patients with pulmonary hypertension caused by systolic left ventricular dysfunction: a phase IIb double-blind, randomized, placebo-controlled, dose-ranging hemodynamic study.
    Bonderman D; Ghio S; Felix SB; Ghofrani HA; Michelakis E; Mitrovic V; Oudiz RJ; Boateng F; Scalise AV; Roessig L; Semigran MJ;
    Circulation; 2013 Jul; 128(5):502-11. PubMed ID: 23775260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Risk profile and survival in patients with heart failure caused by systolic function. Prospective study with 4-year follow-up].
    Solís Olivares CA; Jerjes-Sánchez Díaz C; Archondo Arce T
    Arch Cardiol Mex; 2003; 73(3):197-204. PubMed ID: 14635480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of heart failure exacerbations on anticoagulation: a prospective, observational, pilot cohort study.
    Ripley TL; Harrison D; Germany RE; Adamson PB
    Clin Ther; 2010 Mar; 32(3):506-14. PubMed ID: 20399987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between emerging measures of heart failure processes of care and clinical outcomes.
    Hernandez AF; Hammill BG; Peterson ED; Yancy CW; Schulman KA; Curtis LH; Fonarow GC
    Am Heart J; 2010 Mar; 159(3):406-13. PubMed ID: 20211302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral anticoagulation with warfarin for patients with left ventricular systolic dysfunction.
    Snowden S; Silus L
    Cardiol Rev; 2011; 19(1):36-40. PubMed ID: 21135601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm: an executive summary of a joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis.
    Lip GY; Piotrponikowski P; Andreotti F; Anker SD; Filippatos G; Homma S; Morais J; Pullicino P; Rasmussen LH; Marín F; Lane DA;
    Thromb Haemost; 2012 Dec; 108(6):1009-22. PubMed ID: 23093044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.